Back to search

Article

Humanized CAR T cells targeting p95HER2

2022-05-20

Abstract excerpt

Redirection of T lymphocytes against tumor-associated or tumor-specific antigens, via bispecifc T cells engagers (BiTEs) or chimeric antigen receptors (CARs), is a successful therapeutic strategy against certain hematologic malignancies. In contrast, so far it has failed against solid tumors. Given the scarcity of tumor-specific antigens, the vast majority of BiTEs and CAR Ts developed to date have been directed a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e4cd621-f947-5ca7-9c6c-44382533d182
DOI
10.1101/2022.05.20.492812
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Humanized CAR T cells targeting p95HER2DOI 10.1101/2022.05.20.492812
Select a neighboring publication to make it the new centre.